FACTOR 5 LEIDEN MUTATION/PROTHROMBIN MUTATION(WH)

CONTAINS TWO TEST IN A PANEL ONLY. FACTOR 5 LEIDEN MUTATION, AND PROTHROMBIN MUTATION. CAN NOT ORDER SEPARATELY.

FACT 5 LEIDEN/FACT 2 MUT

FACTOR 2 MUTATION

FACTOR 5 LEIDEN MUTATION, AND PROTHROMBIN MUTATION.

WHOLE BLOOD-LAV TOP TUBE REFRIGERATED

4ML

Draw one LAVENDER (EDTA) top tube. Do not spin or freeze sample. Store whole blood sample in refrigerator.

ORIGINAL TUBE

REFRIGERATED

ONE RUN/WEEK- VARIABLE ON DAY

8 DAYS

Homozygous Normal (Wild-Type)

The Factor II (Prothrombin) G20210A test is an in vitro diagnostic test for the detection and genotyping of the Factor II (Prothrombin) G20210A mutation as an aid to diagnosis in the evaluation of patients with suspected thrombophilia. Inherited thrombophilia predisposes an individual to thrombotic events such as venous thrombosis, the third most common cardiovascular disease . Activated protein C (APC) resistance is regarded as the most prevalent coagulation abnormality associated with venous thrombosis. Patients testing positive for APC resistance or the Factor V Leiden mutation should be considered for molecular genetic testing for the other most common thrombophilias with overlapping phenotype, for which testing is available at present [i.e., the Factor II (Prothrombin) G20210A variant] which is present in 1–2% of the general population and its involvement in venous thromboembolism is well established.